Home Cart Sign in  
Chemical Structure| 347887-36-9 Chemical Structure| 347887-36-9

Structure of Fedovapagon
CAS No.: 347887-36-9

Chemical Structure| 347887-36-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Fedovapagon (VA106483) is a selective vasopressin V2 receptor (V2R) agonist with an EC50 of 24 nM, useful for nocturia research.

Synonyms: VA106483

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Fedovapagon

CAS No. :347887-36-9
Formula : C27H34N4O3
M.W : 462.58
SMILES Code : O=C(N1[C@H](C(N(C)C)=O)CCC1)NCC2=CC=C(C(N3CCCCC4=CC=CC=C43)=O)C=C2C
Synonyms :
VA106483
MDL No. :MFCD19443737
InChI Key :RUOLFWZIFNQQGH-DEOSSOPVSA-N
Pubchem ID :10298385

Safety of Fedovapagon

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of Fedovapagon

GPCR

Isoform Comparison

Biological Activity

Description
Fedovapagon (VA106483) is a vasopressin V2 receptor (V2R) agonist that is both selective and orally active, with an EC50 of 24 nM. Its utility extends to research on nocturia[1].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01038843 Nocturia PHASE2 COMPLETED 2025-08-10 Alabama Research Center, LLC, ... More >>Birmingham, Alabama, 35209, United States|Genova Clinical Research, Tucson, Arizona, 85741, United States|Tower Urology Medical Group, Los Angeles, California, 90048, United States|Grove Hill Clinical Research, New Britian, Connecticut, 06052, United States|South Florida Medical Research, Aventura, Florida, 33180, United States|Discovery Clinical Trials, Celebration, Florida, 34747, United States|Avail Clinical Research LLC, DeLand, Florida, 32720, United States|Urology Center of Florida, Hialeah, Florida, 33012, United States|South Broward Research, LLC, Pembroke Pines, Florida, 33027, United States|Bay State Clinical Trials, Inc., Watertown, Massachusetts, 02472, United States|Medical & Clinical Research Associates, Bayshore, New York, 11706, United States|Accumed Research Associates, Garden City, New York, 11530, United States|Hudson Valley Urology, PC, Poughkeepsie, New York, 12601, United States|Rapid Medical Research, Inc., Clevland, Ohio, 44122, United States|Parkhurst Research Organization, Bethany, Oklahoma, 73008, United States|Urology Associates of North Texas, Arlington, Texas, 76017, United States|The Urology Team P.A., Austin, Texas, 78759, United States|Health Texas Research Institute, San Antonio, Texas, 78212, United States|Martin Diagnostic Clinic, Tomball, Texas, 77375, United States Less <<
NCT01330927 Nocturia|Benign Prostatic Hype... More >>rtrophy (BPH) Less << PHASE1 COMPLETED 2025-07-11 Early Phase Clinical Unit, PAR... More >>EXEL International GmbH, Berlin, 14050, Germany Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.16mL

0.43mL

0.22mL

10.81mL

2.16mL

1.08mL

21.62mL

4.32mL

2.16mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories